1796568-94-9
Chemical Structure
Goralatide TFA
- CAS No.: 1796568-94-9
- Formula:C22H34F3N5O11
- Molecular Weight:601.53
IUPAC Name: acetyl-L-seryl-L-aspartyl-L-lysyl-L-proline compound with 2,2,2-trifluoroacetic acid (1:1)
InChIKey: LKOFRAPICMDYPN-WFGXUCIJSA-N
SMILES: O=C(O)[C@H]1N(C([C@H](CCCCN)NC([C@H](CC(O)=O)NC([C@H](CO)NC(C)=O)=O)=O)=O)CCC1.OC(C(F)(F)F)=O
Biological Activity: Goralatide TFA is an inhibitor of cell cycle progression. Goralatide TFA enhances selectivity of hyperthermic purging of human progenitor cells. Goralatide TFA has the potential for the research of leukemia[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Goralatide TFA | 98.0% | Goralatide TFA is an inhibitor of cell cycle progression. Goralatide TFA enhances selectivity of hyperthermic purging of human progenitor cells. Goralatide TFA has the potential for the research of leukemia. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords